Home
News
Create
Screeners
Insights
Sai Parenteral's
588.
10
-8.00
(-1.34%)
Market Cap
₹2,598.18 Cr
PE Ratio
184.44
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.34%
1M
+5.01%
6M
+44.96%
1Y
+44.96%
5Y
+44.96%
View Company Insights
Latest news about Sai Parenteral's
Sai Parenterals appoints auditors for FY27 and authorizes growth
3 days ago
Sai Parenterals Limited appointed M/s. Aakanksha Dubey & Co. as Secretarial Auditors for 2026-27 to 2030-31, subject to shareholder approval. The board also appointed M/s. NSVR & Associates LLP as Internal Auditors and M/s. Sai Krishna & Associates as Cost Auditors for FY 2026-27. Additionally, Mr. Anil Kumar Karusala was authorized to explore organic and inorganic growth opportunities.
Sai Parenterals subsidiary wins AUD 202 Mn OTC order
8 days ago
Sai Parenterals to host virtual analyst meet on Jul 2
9 days ago
Sai Parenterals targets ₹750 crore revenue in FY27
May 30, 2026
Sai Parenterals secures $11 million anti-TB supply order
May 29, 2026
More news about Sai Parenteral's
28
May 26
Sai Parenterals FY26 PAT rises 45.5% to ₹14.37 Cr
Sai Parenterals reported FY26 PAT of ₹14.37 crore, up 45.5%, driven by CDMO exports and the Noumed acquisition. Consolidated revenue surged 140.4% to ₹380.99 crore.
Sai Parenteral's
588.
10
-
8.
00
(-
1.
34
%)
1 Year Returns:
+44.96%
Industry Peers
Sun Pharmaceutical
1,935.50
(-
0.
17
%)
Divis Laboratories
6,836.00
(+
0.
34
%)
Torrent Pharmaceuticals
4,901.50
(+
0.
07
%)
Cipla
1,439.40
(-
0.
13
%)
Zydus Life Science
1,150.80
(-
0.
71
%)
Lupin
2,496.30
(-
0.
28
%)
Mankind Pharma
2,525.10
(-
0.
27
%)
Dr Reddys Laboratories
1,244.30
(-
1.
36
%)
Aurobindo Pharma
1,564.70
(-
1.
43
%)
Laurus Labs
1,537.80
(+
2.
02
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar